{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System Ticarcillin (1-128 \u03bcg/mL)",
        "BD Phoenix Automated Microbiology System for use with the antimicrobial agent ticarcillin (1-128 \u03bcg/mL) - Gram-Negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K062680",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K031984",
        "K061327"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "October 5, 2006",
    "Summary Letter Received Date": "September 8, 2006",
    "Submission Date": "September 7, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ticarcillin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-negative bacteria",
        "Pure culture isolates of Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix\u2122M Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth based microdilution",
        "Automated redox indicator detection",
        "Turbidity measurement"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Quantitative MIC determination"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "Panel",
        "System",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System with ticarcillin for rapid identification and antimicrobial susceptibility testing of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) for most Gram-negative aerobic and facultative anaerobic bacteria isolates (Enterobacteriaceae and non-Enterobacteriaceae) and most Gram-positive bacteria isolates (Staphylococcus, Enterococcus, Streptococcus) from pure culture.",
    "fda_folder": "Microbiology"
}